Johnson & Johnson (JNJ) said Thursday that the European Commission has granted a Conditional Marketing Authorization for its single-dose COVID-19 vaccine.
The authorization comes hours after receiving a positive opinion from the European Medicines Agency's the Committee for Medicinal Products for Human Use or CHMP for the vaccine.
The CHMP earlier today recommended Conditional Marketing Authorization for the vaccine candidate, developed by Johnson & Johnson's Janssen Pharmaceutical, to prevent COVID-19 in individuals 18 years of age and older.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.